A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Pegylated Lyposomal Doxorubicin|DRUG: Cyclophosphamide
Sponsor: Merck Sharp & Dohme LLC
Collaborators: Princess Margaret Hospital, Canada